For example, some studies have found that supplementing with SCFAs can significantly reduce the lung injury scores, lung wet-to-dry (W/D) ratio, myeloperoxidase (MPO), tumor necrosis factor-alpha (TNF-α), and malondialdehyde (MDA) levels in animal models of ALI (18–20). Here, MPO is linked to acute respiratory distress syndrome.